OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7885$1090.0058

Takano Co Ltd

Business Support SuppliesVerified

Takano maintains a strong liquidity position with a current ratio of 4.22 and cash and equivalents of ¥8.9 billion, which is significantly higher than the median for its industry. The company's price-to-book ratio of 0.52 suggests undervaluation relative to its tangible assets, and its low debt-to-equity ratio of 0.01 indicates minimal leverage risk. Profitability metrics show Takano's return on equity (ROE) at 1.63% and return on assets (ROA) at 1.35%, both below the industry median for Business Support Supplies. The company's operating margin is 1.63%, and its net margin is 0.22%, reflecting modest profitability compared to peers. The company's revenue is distributed across five segments: Living Related Equipment, Inspection and Measurement Equipment, Industrial Equipment, Exterior Product, and Machine and Tool. The Living Related Equipment segment is the largest contributor, with office chairs and medical chairs forming a significant portion of its product mix. The Inspection and Measurement Equipment segment, which includes atomic force microscopes, is a niche but high-margin area. Takano's revenue for the latest period was ¥23.97 billion, with no significant growth reported. The company's outlook for the current fiscal year shows a stable revenue trajectory, with no projected changes in the near term. The absence of capital expenditure growth and low R&D investment suggests a conservative approach to expansion. Risk factors for Takano include low liquidity risk and no immediate dilution pressure. The company has not issued new shares recently, and its diluted share count is equal to its basic share count, indicating no dilution from stock options or convertible securities. The company's low debt levels and strong cash position reduce credit risk. Recent filings and transcripts show no material changes in the company's operations or strategy. The company continues to focus on its core segments and has not announced any major new product lines or market expansions. The absence of significant regulatory or geopolitical exposure aligns with its domestic focus and low international revenue concentration.

30-day price · 7885-230.00 (-18.6%)
Low$1000.00High$1257.00Close$1006.00As of19 May, 00:00 UTC
Profile
CompanyTakano Co Ltd
Ticker7885.T
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryBusiness Support Supplies
AI analysis

Business. Takano Co Ltd designs and sells living-related equipment, inspection and measurement equipment, industrial equipment, and exterior products, primarily in Japan, with revenue derived from office chairs, atomic force microscopes, solenoid actuators, and carports.

Classification. Takano is classified under Industrial & Commercial Services, Business Support Supplies, with 92% confidence based on verified market data.

Takano maintains a strong liquidity position with a current ratio of 4.22 and cash and equivalents of ¥8.9 billion, which is significantly higher than the median for its industry. The company's price-to-book ratio of 0.52 suggests undervaluation relative to its tangible assets, and its low debt-to-equity ratio of 0.01 indicates minimal leverage risk. Profitability metrics show Takano's return on equity (ROE) at 1.63% and return on assets (ROA) at 1.35%, both below the industry median for Business Support Supplies. The company's operating margin is 1.63%, and its net margin is 0.22%, reflecting modest profitability compared to peers. The company's revenue is distributed across five segments: Living Related Equipment, Inspection and Measurement Equipment, Industrial Equipment, Exterior Product, and Machine and Tool. The Living Related Equipment segment is the largest contributor, with office chairs and medical chairs forming a significant portion of its product mix. The Inspection and Measurement Equipment segment, which includes atomic force microscopes, is a niche but high-margin area. Takano's revenue for the latest period was ¥23.97 billion, with no significant growth reported. The company's outlook for the current fiscal year shows a stable revenue trajectory, with no projected changes in the near term. The absence of capital expenditure growth and low R&D investment suggests a conservative approach to expansion. Risk factors for Takano include low liquidity risk and no immediate dilution pressure. The company has not issued new shares recently, and its diluted share count is equal to its basic share count, indicating no dilution from stock options or convertible securities. The company's low debt levels and strong cash position reduce credit risk. Recent filings and transcripts show no material changes in the company's operations or strategy. The company continues to focus on its core segments and has not announced any major new product lines or market expansions. The absence of significant regulatory or geopolitical exposure aligns with its domestic focus and low international revenue concentration.
Key takeaways
  • Takano has a strong liquidity position with a current ratio of 4.22 and ¥8.9 billion in cash and equivalents.
  • The company's ROE and ROA are below industry medians, indicating modest profitability.
  • Revenue is concentrated in five segments, with the Living Related Equipment segment being the largest.
  • No significant growth or capital expenditure is expected in the near term.
  • Low debt and no dilution risk contribute to a stable financial profile.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$23.97B
Gross profit$5.40B
Operating income$390.3M
Net income$520.5M
R&D
SG&A
D&A
SBC
Operating cash flow$836.1M
CapEx-$819.1M
Free cash flow$355.9M
Total assets$38.47B
Total liabilities$6.56B
Total equity$31.91B
Cash & equivalents$8.91B
Long-term debt$257.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1090.00
Market cap$16.59B
Enterprise value$7.94B
P/E31.9
Reported non-GAAP P/E
EV/Revenue0.3
EV/Op income20.4
EV/OCF9.5
P/B0.5
P/Tangible book0.5
Tangible book$31.91B
Net cash$8.65B
Current ratio4.2
Debt/Equity0.0
ROA1.4%
ROE1.6%
Cash conversion1.6%
CapEx/Revenue-3.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Industrial Services · cohort 6 companies
Metric7885Activity
Op margin1.6%11.2% medp25 7.1% · p75 18.5%bottom quartile
Net margin2.2%13.8% medp25 13.8% · p75 13.8%bottom quartile
Gross margin22.5%94.7% medp25 62.9% · p75 126.4%bottom quartile
R&D / revenue6.0% medp25 6.0% · p75 6.0%
CapEx / revenue-3.4%6.7% medp25 4.4% · p75 7.4%bottom quartile
Debt / equity1.0%136.7% medp25 101.5% · p75 217.7%bottom quartile
Observations
IR observations
Last actual EPS34.19 JPY
Last actual revenue23,969,640,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 11:10 UTC#2e6acd48
Market quoteclose JPY 1090.00 · shares 0.02B diluted
no public URL
2026-05-10 11:10 UTC#f21cc29a
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 11:12 UTCJob: cfbdb755